Ueno Y, Saito A, Nakata J, Kamagata K, Taniguchi D, Motoi Y, et al
PMID: Summary Keywords GLP-1 receptor agonists, medullary thyroid carcinoma, mRNA expression, papillary thyroid carcinoma, TCGA database Citation Kennedy S, Thomas J, DArcy S, Odia I, Kamdar D, Pereira L, Scarola D, Miles B, Frank D, Taneja C, Seetharamu N and Mandal R (2026) Glucagon-like peptide-1 receptor (GLP-1R) overexpression defines a distinct immunogenetic subset in primary and metastatic thyroid cancer: implications for GLP-1R agonist therapy
It means nutrition support isn't just filling a clinical gap, it can make the medication itself work better
Our offices in Lexington, Louisville, and London provide ongoing support as you navigate your weight loss experience
long COVID), severity (patient capacity level), and demographics of patients ( SI Appendix , Fig
321 , E11E23 (2021)